glp-1-based therapy The Benefits of GLP-1 Therapy: Beyond Weight Loss The GLP-1 revolution: What UAB

J Neurochem 146(2):173185 Deng H, Yang F, Ma X, Wang Y, Chen Q, Yuan L (2020) Long-Term Liraglutide Administration Induces Pancreas Neogenesis in Adult T2DM Mice

Diabetes & endocrinology

Quad-agonists and even more complex multi-receptor compounds are already in preclinical development

CLINICAL APPLICATION OF GLP-1 IN LIPID METABOLISM AND ADIPOSE-RELATED DISORDERS Effects of glp-/glucose-dependent insulinotropic peptide dual agonists on lipid metabolism GLP-/glucose-dependent insulinotropic peptide (GIP) dual agonists are a new type of oral hypoglycemic drug, which can activate both GLP-1 and GIP incretin at the same time, thereby exerting a more comprehensive blood glucose control effect [125]